Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hirsutes. II: Treatment

R Young1, R Sinclair

  • 1University of Melbourne, Department of Medicine (Dermatology), St Vincent's Hospital, Melbourne, Fitzroy, Victoria, Australia.

The Australasian Journal of Dermatology
|September 16, 1998
PubMed
Summary

Hirsutism treatments range from cosmetic procedures like laser epilation to pharmacological options. Anti-androgens, oral contraceptives, and emerging therapies like finasteride offer diverse approaches to managing hirsutism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Long-term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO-LT phase 3, open-label study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Long-term efficacy and safety of baricitinib in patients with severe alopecia areata: 104-week results from BRAVE-AA1 and BRAVE-AA2.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Incidence and prevalence of alopecia areata in the Australian primary care setting: A retrospective analysis of electronic health record data.

The Australasian journal of dermatology·2023
Same author

Phase 2 BELIEVE study part B: Efficacy and safety of rilzabrutinib for patients with pemphigus vulgaris.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Alopecia areata: progress, but who pays?

The British journal of dermatology·2021

Area of Science:

  • Endocrinology
  • Dermatology
  • Pharmacology

Background:

  • Hirsutism, characterized by excessive hair growth, affects many women.
  • Current treatments include cosmetic procedures and various medications.

Purpose of the Study:

  • To review current and emerging treatments for hirsutism.
  • To discuss the mechanisms of action for different therapeutic options.

Main Methods:

  • Literature review of cosmetic and pharmacological interventions for hirsutism.
  • Analysis of drug classes including anti-androgens, oral contraceptives, and inhibitors.

Main Results:

  • Cosmetic options: bleaching, plucking, electrical and laser epilation.
  • Pharmacological options: anti-androgens (spironolactone, cyproterone acetate), oral contraceptives, corticosteroids.
  • Emerging therapies: finasteride (5 alpha reductase inhibitor), flutamide (anti-androgen), gonadotrophin-releasing hormone agonists.

Conclusions:

  • A range of treatment modalities exist for hirsutism.
  • Pharmacological treatments target androgen production or action.
  • Newer agents show promise for more effective hirsutism management.

Related Experiment Videos